THYMIC CARCINOMA
Clinical trials for THYMIC CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new THYMIC CARCINOMA trials appear
Sign up with your email to follow new studies for THYMIC CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare chest cancer patients after other treatments fail
Disease control Recruiting nowThis study is testing whether a drug called sacituzumab govitecan can help control advanced thymoma and thymic carcinoma in adults whose cancer has continued to grow despite previous treatments. Participants will receive the drug through an IV every three weeks until their cancer…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Apr 03, 2026 14:41 UTC
-
New 'Living Drug' trial targets multiple advanced cancers
Disease control Recruiting nowThis early-stage study is testing a new type of personalized immune cell therapy (CAR-T) for people with advanced solid tumors that have a specific marker called CD70. The main goals are to find a safe dose and see how the body handles the treatment. It is for adults with cancers…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE1 • Sponsor: Chongqing Precision Biotech Co., Ltd • Aim: Disease control
Last updated Mar 30, 2026 14:29 UTC
-
New drug duo tested for rare chest cancers
Disease control Recruiting nowThis study is testing whether a combination of two drugs, tislelizumab and anlotinib, can help control thymoma or thymic carcinoma in patients whose cancer has grown despite initial chemotherapy. It will enroll about 20 adults in China to see if the treatment is safe and effectiv…
Matched conditions: THYMIC CARCINOMA
Phase: PHASE2 • Sponsor: The First Affiliated Hospital with Nanjing Medical University • Aim: Disease control
Last updated Mar 18, 2026 14:40 UTC